Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 2014

View Archived Issues

UCP2 -866G/A polymorphism and genotypes as prognostic markers for ischemic stroke

Novel dual histamine H1/H4 antagonists presented for allergic conjunctivitis

New company Nurix launched with focus on the ubiquitin proteasome system

BioRestorative Therapies signs research agreement with Pfizer

IXICO gains additional Huntington's disease trial contracts

Novel TNF-alpha-expressing oncolytic adenovirus demonstrates antitumor activity

Pharmaxis' LOXL2 inhibitors show promise for fibrosis

U.S. researchers prepare novel nucleosides and prodrugs

CHMP adopts positive opinion for Plegridy as a treatment for multiple sclerosis

Retriacyl obtains FDA orphan drug status for RP

Salk's Glenn Center for Aging Research receives USD 3 million gift

Viking Therapeutics licenses five programs from Ligand Pharmaceuticals

Daiichi Sankyo receives additional indication approval in Japan for Ranmark

European researchers disclose new anti-S100-A4 MAbs

Shionogi patents novel AMPK activators for diabetes

Boehringer Ingelheim patent reports new CMV inhibitors

New E-selectin inhibitors designed by GlycoMimetics

FDA approves EkoSonic endovascular system

EMA committee makes Halaven recommendation

EMA's CHMP recommends approval of Simbrinza to reduce IOP

EMA committee hands down positive opinion on Arzerra for CLL

EMA recommends approval of Nuwiq for children and adults with hemophilia A

Elixir Medical presents results on CE Mark-approved novolimus-eluting coronary intervention systems

Pfizer rules out new offer for AstraZeneca

Taliglucerase alfa approved in Australia for Gaucher's disease

EMA's CHMP confirms negative opinion for RLX-030

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...